Sort
16,179 grants matching “malaria”
SYSTEMIC AND EPITHELIAL INSECT IMMUNITY
$256,646Massachusetts General Hospital · P01 · FY2000 · AI
Discovery of Small Molecules as Antimalarial Agents
$256,500Shuren Zhu · Cascade Therapeutics, Inc. · R43 · FY2021 · AI
Inhibitor class dependent consequences of prolyl-tRNA synthetase inhibition in Plasmodium falciparum
$256,500Ralph Mazitschek · Massachusetts General Hospital · R21 · FY2017 · AI
IDENTIFICATION AND EXPRESSION ANALYSIS OF ABC GENES IN PLASMODIUM YOELII
$256,483Ivan Ferrer · University Of Puerto Rico · P20 · FY2007 · RR
DISEASE DYNAMICS FOLLOWING MULTIPLE VECTOR INTRODUCTIONS
$256,475Smithsonian Institution · R01 · FY2004 · GM
Training in Parasitology and Vector Biology
$256,397Christian Tschudi · Yale University · T32 · FY2015 · AI
Shared Laboratory Resource Core
$256,333Jorge Arevalo · University Of California, San Diego · U19 · FY2014 · AI
Building a Technology Trust in Genomics
$256,236Anthony D So · Duke University · R01 · FY2008 · HG
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges
$256,142David C Perlman · New York University · P30 · FY2019 · DA
Elucidating the transport mechanisms in the parasitophorous vacuole of Plasmodium
$256,102Manuel Antonio Fierro · Clemson University · P20 · FY2025 · GM
Risk stratification of malaria among school-age children with mHealth spectroscopy of blood analysis
$256,048Young L Kim · Purdue University · R33 · FY2024 · TW
Genetics & Population Structure of Plasmodium falciparum
$256,047Stephen M Rich · University Of Massachusetts Amherst · R01 · FY2007 · GM
Howard University Research Scientist Award
$256,009Sergei Nekhai · Howard University · R25 · FY2009 · HL
STTR Phase I: Recombinant BCG as a novel immunoadjuvant for viral infections
$256,000Todd Wallach · Oncosting Llc · · FY2022 · TIP
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges
$255,982David C Perlman · New York University · P30 · FY2021 · DA
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges
$255,976David C Perlman · New York University · P30 · FY2022 · DA
SBIR Phase I: Stable prophylactic antibodies
$255,927Arthur Young · Invvax, Inc. · · FY2022 · TIP
HEALTH DISPARITIES RESEARCH THROUGH INTERNATIONAL EXCHANGE
$255,919Winston Anthony Anderson · Howard University · T37 · FY2016 · MD
HEALTH DISPARITIES RESEARCH THROUGH INTERNATIONAL EXCHANGE
$255,919Winston Anthony Anderson · Howard University · T37 · FY2017 · MD
HEALTH DISPARITIES RESEARCH THROUGH INTERNATIONAL EXCHANGE
$255,919Broderick Erorewaen Eribo · Howard University · T37 · FY2018 · MD
Mali International Center for Excellence in Research: Malaria immunology
$255,913Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Phenotypic Assay Design and Development for Rare and Neglected Diseases
$255,534James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Characterizing the role of the 22 up-regulated genes in mosquito resistance
$255,500Nannan Liu · Auburn University At Auburn · R21 · FY2010 · AI
High-density linkage map to find snail genes that block schistosome transmission
$255,500Michael Scott Blouin · Oregon State University · R21 · FY2015 · AI
Human and Vector Drivers of Transmission and Enhanced Surveillance for Early Outbreak Detection and Monitoring Progress Toward Elimination
$255,365William J Moss · Johns Hopkins University · U19 · FY2024 · AI